Publications

Detailed Information

High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma

DC Field Value Language
dc.contributor.authorChung, Goh Eun-
dc.contributor.authorYoon, Jung-Hwan-
dc.contributor.authorMyung, Sun Jung-
dc.contributor.authorLee, Jeong-Hoon-
dc.contributor.authorLee, Soo-Mi-
dc.contributor.authorHwang, Seung Yong-
dc.contributor.authorKim, Chung Yong-
dc.contributor.authorLee, Hyo-Suk-
dc.contributor.authorKim, Seung-Jun-
dc.contributor.authorLee, Sung-Hee-
dc.date.accessioned2012-06-25T05:04:23Z-
dc.date.available2012-06-25T05:04:23Z-
dc.date.issued2010-01-
dc.identifier.citationONCOLOGY REPORTS; Vol.23 1; 113-119ko_KR
dc.identifier.issn1021-335X-
dc.identifier.urihttps://hdl.handle.net/10371/77381-
dc.description.abstractMicroRNAs (miRNA) have recently been implicated in carcinogenesis and tumor progression. Hepatocellular carcinoma (HCC) is well known for frequent relapses following curative resection. We attempted to identify the miRNAs associated with HCC recurrence. We analyzed miRNA expression profiles in 25 pairs of HCC and adjacent non-tumor liver tissues from HCC patients using miRNA microarray. Out of 449 miRNAs assayed, we identified seven miRNAs associated with HCC recurrence. In particular, the highest ranked miR-15b was negatively correlated with recurrence. MiR-15b inhibitor transfection increased HCC cell proliferation and inhibited TRAIL-induced apoptosis, while miR-15b precursor transfection decreased proliferation and enhanced apoptosis. Bcl-w was identified as a target molecule regulated by miR-15b. These results indicate that miR-15b expression in HCC tissues may predict a low risk of HCC recurrence. In addition, the modulation of miR-15b expression may be useful as an apoptosis-sensitizing strategy for HCC treatment.ko_KR
dc.description.sponsorshipThis study was supported by the Seoul National University
Hospital Research Fund (#03-2006-019) and the Korean
Foundation of Liver Research (2008) and the Korea Health 21
R&D Project (#0412-CR01-0704-0001).
ko_KR
dc.language.isoenko_KR
dc.publisherSPANDIDOS PUBL LTDko_KR
dc.subjectmiR-15bko_KR
dc.subjectBcl-wko_KR
dc.subjectapoptosisko_KR
dc.subjectrecurrenceko_KR
dc.subjecthepatocellular carcinomako_KR
dc.titleHigh expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinomako_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor정고은-
dc.contributor.AlternativeAuthor윤정환-
dc.contributor.AlternativeAuthor명선정-
dc.contributor.AlternativeAuthor이정훈-
dc.contributor.AlternativeAuthor이성희-
dc.contributor.AlternativeAuthor이수미-
dc.contributor.AlternativeAuthor김승준-
dc.contributor.AlternativeAuthor황승용-
dc.contributor.AlternativeAuthor이효석-
dc.contributor.AlternativeAuthor김청용-
dc.identifier.doi10.3892/or_00000612-
dc.citation.journaltitleONCOLOGY REPORTS-
dc.description.citedreferenceXia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169-
dc.description.citedreferenceLiu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355-
dc.description.citedreferenceLin CJF, 2008, BIOCHEM BIOPH RES CO, V375, P315, DOI 10.1016/j.bbrc.2008.07.154-
dc.description.citedreferenceSchepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110-
dc.description.citedreferenceXia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501-
dc.description.citedreferenceCho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60-
dc.description.citedreferenceCalin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997-
dc.description.citedreferenceRoldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194-
dc.description.citedreferenceSeeff LB, 2006, ONCOGENE, V25, P3771, DOI 10.1038/sj.onc.1209560-
dc.description.citedreferenceMurakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283-
dc.description.citedreferenceYanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025-
dc.description.citedreferenceVolinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103-
dc.description.citedreferenceDavison TS, 2006, METHOD ENZYMOL, V411, P14, DOI 10.1016/S0076-6879(06)11002-2-
dc.description.citedreferenceCimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102-
dc.description.citedreferenceLu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702-
dc.description.citedreferenceParkin DM, 2005, CA-CANCER J CLIN, V55, P74-
dc.description.citedreferenceLORIO MV, 2005, CANCER RES, V65, P7065-
dc.description.citedreferenceBARTEL IP, 2004, CELL, V116, P281-
dc.description.citedreferenceCalin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799-
dc.description.citedreferenceEl-Serag HB, 2001, HEPATOLOGY, V33, P62-
dc.description.citedreferenceYoon JH, 2000, FEBS LETT, V474, P175-
dc.description.citedreferenceGibson L, 1996, ONCOGENE, V13, P665-
dc.description.citedreferenceKWO P, 1995, AM J PHYSIOL-GASTR L, V268, pG613-
dc.description.citedreferenceBENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289-
dc.description.tc10-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share